| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/05/2007 | US20070155751 Imidazo(1,2-a)pyrazine compounds |
| 07/05/2007 | US20070155750 Integrin-binding small molecules |
| 07/05/2007 | US20070155749 Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 07/05/2007 | US20070155747 Inhibitors of fatty acid amide hydrolase |
| 07/05/2007 | US20070155746 Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinases |
| 07/05/2007 | US20070155745 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 07/05/2007 | US20070155744 N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4- carboxamide compounds useful as hiv integrase inhibitors |
| 07/05/2007 | US20070155743 suchas N-(4(S)-amino-5(S)-hydroxy-2(S)-isopropyl-6-piperidin-1-ylhexyl)-2-(3-methoxypropoxy)benzamide dihydrochloride, used for the treatment of hypertension, cardiovasculr disorders, complications owing to diabetes, vision deffects, hyperaldosteronism, states of anxiety and cognitive disorders |
| 07/05/2007 | US20070155742 inhibiting excessive nitric oxide or prostaglandin formation; cancer, Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotropic lateral sclerosis, rheumatoid arthritis, inflammatory bowel disease |
| 07/05/2007 | US20070155741 R-6-Hydroxy-8-{1-hydroxy-2-[2-(4-methoxy-phenyl)-1,1-dimethyl-ethylamino ]-ethyl}-4H-benzo[1,4]oxazin-3-one, or an acid addition salt thereof; betamimetics; for administration once a day for treating COPD |
| 07/05/2007 | US20070155740 1-(1H-Pyrazin-2-on-3-yl)-tetrahydroquinolines or tetrahydro-1,4-benzoxazines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); affective disorder, anxiety and depression |
| 07/05/2007 | US20070155739 Substituted bis-amide metalloprotease inhibitors |
| 07/05/2007 | US20070155738 Heterobicyclic metalloprotease inhibitors |
| 07/05/2007 | US20070155737 Heterobicyclic metalloprotease inhibitors |
| 07/05/2007 | US20070155736 Fluorinated phno and analogues thereof |
| 07/05/2007 | US20070155735 Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 07/05/2007 | US20070155734 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/05/2007 | US20070155733 1-[4-(2-Dimethylaminoethoxy)phenylcarbonyl]-3,5-bis(phenylmethylene)-4-piperidone hydrochloride; useful in reversing multidrug resistance |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/05/2007 | US20070155731 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity |
| 07/05/2007 | US20070155730 Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase |
| 07/05/2007 | US20070155729 Therapeutic amine-arylsulfonamide conjugate compounds |
| 07/05/2007 | US20070155728 Substituted Heterocyclic Compounds |
| 07/05/2007 | US20070155727 Amide inhibitors of leukotriene A4 hydrolase |
| 07/05/2007 | US20070155726 4-[[(1S,4S)-5-[(4-phenoxyphenyl)methyl]-2,5-diazabicyclo[2.2.1]hept-2-yl]methyl]benzoic acid, useful in treating inflammatory disorders |
| 07/05/2007 | US20070155725 N-(1-Aza-bicyclo[2.2.2]oct-3-yl)-5-cyano-2-(3,5-dichloro-phenoxy)-benzenesulfonamide; asthma, allergic rhinitis or lung granuloma, HIV; CC type chemokine receptor antagonist |
| 07/05/2007 | US20070155724 Methods of Treating Cytokine Mediated Diseases |
| 07/05/2007 | US20070155723 Tetrahydro-pyranopyrazole cannabinoid modulators |
| 07/05/2007 | US20070155722 Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms |
| 07/05/2007 | US20070155721 inflammatory conditions, allergies, autoimmune diseases, chronic pain, graft rejection, cancers which involve leukocyte filtration, stenosis or restenosis, atherosclerosis, rheumatoid arthritis, osteoarthritis; e.g. 4-Isobutoxy-1H-indole-2-carboxylic acid [4-(2-azepan-1-yl-ethyl)-phenyl]-amide |
| 07/05/2007 | US20070155720 Co-administration of dopamine-receptor binding compounds |
| 07/05/2007 | US20070155719 Platelet ADP receptor inhibitors |
| 07/05/2007 | US20070155718 Caspase inhibitor prodrugs |
| 07/05/2007 | US20070155717 Amidines and derivatives thereof and pharmaceutical compositions containing them |
| 07/05/2007 | US20070155716 Hcv inhibiting bi-cyclic pyrimidines |
| 07/05/2007 | US20070155715 Rifamycin analogs and uses thereof |
| 07/05/2007 | US20070155714 Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
| 07/05/2007 | US20070155713 Nitrogen-containing heterocyclic compounds and use thereof |
| 07/05/2007 | US20070155712 Compounds for the inhibition of angiogenesis and use thereof |
| 07/05/2007 | US20070155711 a steroidal quinol that is converted to a biologically active estrogen compound via enzyme catalyzed reduction; 2-(1-adamantyl)-estra-1,3,5(10)-triene-17-one; estrogen receptors activator; low lipid solubility; cataract, glaucoma, conjunctivitis, diabetic retinopathy |
| 07/05/2007 | US20070155710 Administering dehydroisoandrosterone; then harvesting and fertilizing oocytes |
| 07/05/2007 | US20070155709 New Chemical Entities with Multiple Modes of Anti-inflammatory Action |
| 07/05/2007 | US20070155708 e.g. 7-(4-fluorophenyl) sancycline; for treating tetracycline responsive states; antibiotic resistance; rickettsiae: pneumococci and Salmonella |
| 07/05/2007 | US20070155707 Ionizable inhibitors of fatty acid amide hydrolase |
| 07/05/2007 | US20070155705 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
| 07/05/2007 | US20070155704 t-Butyl 1-[9-[1-(tert-butoxycarbonyl)cyclopropyl]-5-oxononyl]-1-cyclopropanecarboxylate; Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, impotence |
| 07/05/2007 | US20070155703 Pharmaceutically active compounds and methods of use thereof |
| 07/05/2007 | US20070155702 which is a hemiethanolate octahydrate of di-sodium salt, used in the treatment of human immunodeficiency virus infection and/or acquired immunodeficiency syndrome |
| 07/05/2007 | US20070155701 Keto cannabinoids with therapeutic indications |
| 07/05/2007 | US20070155700 Use of lipid conjugates in the treatment of conjunctivitis |
| 07/05/2007 | US20070155699 Boron-containing small molecules |
| 07/05/2007 | US20070155698 Oxazaborolidines as bacteria effectors |
| 07/05/2007 | US20070155697 Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms |
| 07/05/2007 | US20070155696 Efficiently producing a macrolide compound, in which a cyclodextrin is made to be present in a culture broth of actinomycetes; antitumor agents |
| 07/05/2007 | US20070155695 Flavonoid complexes with cyclodextrins |
| 07/05/2007 | US20070155694 Low molecular weight polysaccharides having antithrombotic activity |
| 07/05/2007 | US20070155693 Inhibitor of cancer bone metastasis |
| 07/05/2007 | US20070155692 Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation |
| 07/05/2007 | US20070155689 Methods of regulating growth and death of cancer cells |
| 07/05/2007 | US20070155687 Methods and compositions for altering cell function |
| 07/05/2007 | US20070155685 Pharmaceutical composition |
| 07/05/2007 | US20070155683 Containing a single-stranded oligonucleotide DNA molecule containing one or more CpG(s); SARS virus, hepatitis C virus, dengue virus and Japanese encephalitis, influenza virus |
| 07/05/2007 | US20070155681 Methods and compositions for treatment of viral infections |
| 07/05/2007 | US20070155679 Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations |
| 07/05/2007 | US20070155678 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 07/05/2007 | US20070155677 Separation method |
| 07/05/2007 | US20070155676 Vascular conditions such as atherosclerosis, hypercholesterolemia, diabetes, obesity, stroke, demyelination; lowering plasma levels of sterols and/or stanols |
| 07/05/2007 | US20070155675 Substituted azetidinone compunds, processes for preparing the same, formulations and uses thereof |
| 07/05/2007 | US20070155674 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 07/05/2007 | US20070155673 Preferentiasl killing by contacting cell with 5-bromovinyl-2-deoxyuridine; anticancer agents |
| 07/05/2007 | US20070155672 Sterilized peritoneal dialysis solutions containing heparin |
| 07/05/2007 | US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction |
| 07/05/2007 | US20070155670 Pyrrolidine Melanocortin-Specific Compounds |
| 07/05/2007 | US20070155669 Prostate adenocarcinoma; bicalutamide non-steroidal anti-androgen, luteinizing hormone, luteinizing hormone-releasing hormone, LH-RH leuprorelin acetate agonist; microwave radiation by transurethral microwave thermoablation; laser; chemicals and radiation may or may not be administered simultaneously |
| 07/05/2007 | US20070155664 Parathyroid hormone (pth) containing pharmaceutical compositions for oral use |
| 07/05/2007 | US20070155663 Use of chemokine receptor agonists for stem cell transplantation |
| 07/05/2007 | US20070155657 Hypoglycemic agent |
| 07/05/2007 | US20070155656 Hypoglycemic agent |
| 07/05/2007 | US20070155655 Zinc (vitamin C)2 complex; low toxicity; insulin mimetics; stability; fat soluble; diabetes |
| 07/05/2007 | US20070155654 Novel formulations |
| 07/05/2007 | US20070155652 Composition for regenerative treatment of cartilage disease |
| 07/05/2007 | US20070154991 Transgenic bacillus for use as bioreactor in production of capsular polysaccharide A |
| 07/05/2007 | US20070154961 Cell separation compositions and methods |
| 07/05/2007 | US20070154948 Novel antibacterial agents |
| 07/05/2007 | US20070154918 44 Human Secreted Proteins |
| 07/05/2007 | US20070154912 87 Human Secreted Proteins |
| 07/05/2007 | US20070154583 Treatment Of Inflammatory Bowel Disease |
| 07/05/2007 | US20070154582 Preventative and Treatment Effects of Morinda Citrifolia as an Aromatase Inhibitor |
| 07/05/2007 | US20070154581 Composition and method for enhancing or stimulating the immune system |
| 07/05/2007 | US20070154576 Protein kinase modulation by hops and Acacia products |
| 07/05/2007 | US20070154575 Anti-inflammatory agent |
| 07/05/2007 | US20070154562 Inhalable biodegradable microparticles for target-specific drug delivery in tuberculosis and a process thereof |
| 07/05/2007 | US20070154559 comprising 0.1-30 weight % complex of water-soluble drug and counter-ion substance in which charged water-soluble drug is bonded with counter-ion substance, 0.5-80 weight % lipid, 0.5-80 weight % polymer, and 1-80 weight % emulsifier; high gastrointestinal absorption rate; high drug entrapping rate |
| 07/05/2007 | US20070154553 also contains a pharmacologically active substance and a stimulus-responsive compound comprising an azobenzene group or a stilbene group |
| 07/05/2007 | US20070154551 Coating method |
| 07/05/2007 | US20070154550 Pharmaceutical composition comprising anticonvulsant with taste mask coating |
| 07/05/2007 | US20070154548 Controlled release metformin formulations |
| 07/05/2007 | US20070154546 Sustained release pharmaceutical compositions |
| 07/05/2007 | US20070154545 Dry formulations of aripiprazole |
| 07/05/2007 | US20070154544 Wet formulations of aripiprazole |